On July 30, PHARMARON fell 5.08% in regular trading, trading at 22.0 HKD/share, with turnover of approximately 81.99 million HKD.
Within the Life Sciences Tools & Services sector where PHARMARON belongs, the overall sector experienced broad weakness. Among individual stocks, WUXI BIO down 5.94%, INSILICO down 5.29%, GENSCRIPT BIO down 5.0%, WUXI APPTEC down 4.16%, XTALPI down 3.09%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)